<DOC>
	<DOCNO>NCT00002526</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy consist ifosfamide doxorubicin patient advance sarcoma .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Advanced Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , time treatment failure , survival patient advance soft tissue gynecological sarcoma treat high-dose ifosfamide doxorubicin . OUTLINE : Patients receive ifosfamide IV continuously day 1-5 doxorubicin IV day 1-3 . Filgrastim ( G-CSF ) administer subcutaneously daily begin 24 hour completion ifosfamide infusion continue day 16 ( day 20 blood count recover day 16 ) . Courses repeat every 3 week absence disease progression unacceptable toxicity . Patients follow treatment failure annually thereafter . PROJECTED ACCRUAL : A total 16-46 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced soft tissue gynecologic sarcoma Measurable disease No brain metastasis ( CT scan require metastasis clinically suspect ) PATIENT CHARACTERISTICS : Age : 18 70 Performance status : WHO 02 Hematopoietic : WBC least 3,500/mm3 Platelet count least 100,000/mm3 Hepatic : Liver function test great 2 time normal Albumin 4.06.0 g/dL Renal : Creatinine clearance least 60 mL/min Cardiovascular : Cardiac function normal MUGA scan echocardiogram Other : No prior concurrent malignancy except radically remove nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy bladder No prior radiotherapy indicator lesion Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>